Century Therapeutics, Inc. (IPSC) Tops Q2 EPS by 7c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $430 thousand.

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
• Third Century Bancorp (TDCB) Declares $0.06 Quarterly Dividend; 1.5% Yield
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance